rs2153157 — SYCP2L SYCP2L splice-efficiency variant

SYCP2L rs2153157 — The Splice Switch That Calibrates Your Ovarian Clock

Inside the nucleus of every primordial follicle oocyte, a molecular scaffold called the synaptonemal complex zips homologous chromosomes together and guides the recombination that generates genetic diversity. SYCP2L — synaptonemal complex protein 2-like — is the centromere anchor of that scaffold, expressed exclusively in oocytes and essential for primordial follicle survival. The rs2153157 variant determines how efficiently a critical intron in the SYCP2L gene is spliced, calibrating how much functional protein your oocytes can produce across your reproductive lifetime.

The Mechanism

rs2153157 sits within intron 4 of SYCP2L, inside a U12-type minor intron¹¹ U12-type minor intron
a rare class of introns processed by the minor spliceosome, comprising less than 0.5% of all human introns; characterised by AT-AC terminal dinucleotides rather than the canonical GT-AG. The variant changes a single nucleotide at a position critical for minor spliceosome recognition. The A allele is spliced significantly more efficiently than the G allele in mouse oocytes, generating more complete SYCP2L transcript. The G allele reduces splicing efficiency, lowering the steady-state level of SYCP2L mRNA — and therefore the amount of protein available to stabilise oocyte centromeres during meiotic prophase I.

The consequence of insufficient SYCP2L was demonstrated in knockout mice: female animals lacking the protein undergo a significantly accelerated loss of primordial oocytes with age²² significantly accelerated loss of primordial oocytes with age
the reserve of immature oocytes laid down before birth; once depleted, they cannot be replaced, and become subfertile earlier than wild-type controls. At the clinical extreme, complete loss-of-function mutations in SYCP2L cause premature ovarian insufficiency (POI) in humans, with secondary amenorrhoea, undetectable AMH, and elevated FSH before age 40.

The Evidence

The 6p24.2/SYCP2L locus was first associated with age at natural menopause in a 2009 GWAS of 17,438 women (PMID 19448621), where rs2153157 emerged as a lead variant. The association was subsequently confirmed in the landmark Ruth et al. 2021 meta-analysis³³ Ruth et al. 2021 meta-analysis
Genetic insights into biological mechanisms governing human ovarian ageing. Nature 596:393 of 201,323 women — one of the best-powered studies of ovarian aging genetics ever conducted. The SYCP2L locus ranks among the strongest single-gene effects on menopause timing in that study.

Functional validation came from Zhou et al. 2015⁴⁴ Zhou et al. 2015
Accelerated reproductive aging in females lacking a novel centromere protein SYCP2L. Hum Mol Genet 24:6505–6514, who demonstrated the mechanistic link: the A allele of rs2153157 splices its U12-type intron more efficiently in oocytes, explaining at a molecular level why the A allele associates with later menopause in GWAS data.

Clinically, Rosa et al. 2023⁵⁵ Rosa et al. 2023
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes. JBRA Assist Reprod 27:428–435 found that women carrying the AA genotype at rs2153157 had significantly lower AMH levels (2.9 ng/mL) compared to heterozygous GA carriers (3.7 ng/mL; p=0.01) in a cross-sectional study of 149 IVF patients. In a larger IVF cohort of 471 cycles, Laisk-Podar et al. 2015⁶⁶ Laisk-Podar et al. 2015 found this variant associated with the amount of rFSH required per oocyte retrieved (p=0.049) and with biochemical and clinical pregnancy rates (p=0.024 and 0.011).

Practical Actions

Because rs2153157 acts through SYCP2L expression in oocytes, monitoring anti-Müllerian hormone (AMH) provides a direct window into whether the variant's predicted effect on reserve is materialising. AMH is secreted by growing follicles and is the most sensitive early marker of declining reserve — detectable reductions occur years before any change in menstrual cycle regularity or FSH levels.

For GG carriers, a proactive AMH baseline before age 33 allows time to act on a declining trajectory. Coenzyme Q10 in the ubiquinol form has the strongest evidence base for supporting mitochondrial function in aging oocytes, where ATP availability intersects with the chromosome-pairing process that SYCP2L governs.

Interactions

rs2153157 and rs9348724 are two independent signals at the same SYCP2L locus on chromosome 6p24.2. rs9348724 is a regulatory variant ~2 kb upstream of the gene, while rs2153157 is the intronic splice-efficiency variant. They are not in complete linkage disequilibrium — a carrier of the unfavourable allele at one position may or may not carry it at the other. Women who carry the risk allele at both positions may have more severely impaired SYCP2L expression, with a compound effect on oocyte survival and menopause timing.